(105 days)
The OptiLock Implantable Port is designed for patients who require repeated long-term access to the vascular system for intravascular injection or continuous infusion of filtids, medications, antiblotics, nutritionals, and the withdrawl of blood samples.
OptiLock Implantable Port
This is a 510(k) clearance letter for a medical device (OptiLock Implantable Port), not a study report. Therefore, the document does not contain information about acceptance criteria, device performance, sample sizes, ground truth establishment, or clinical study methodologies.
The FDA 510(k) clearance process determines "substantial equivalence" to a legally marketed predicate device, rather than requiring new clinical studies to prove effectiveness or safety by meeting specific performance criteria.
Therefore, I cannot provide the requested information from the given input.
§ 880.5965 Subcutaneous, implanted, intravascular infusion port and catheter.
(a)
Identification. A subcutaneous, implanted, intravascular infusion port and catheter is a device that consists of a subcutaneous, implanted reservoir that connects to a long-term intravascular catheter. The device allows for repeated access to the vascular system for the infusion of fluids and medications and the sampling of blood. The device consists of a portal body with a resealable septum and outlet made of metal, plastic, or combination of these materials and a long-term intravascular catheter is either preattached to the port or attached to the port at the time of device placement. The device is available in various profiles and sizes and can be of a single or multiple lumen design.(b)
Classification. Class II (special controls) Guidance Document: “Guidance on 510(k) Submissions for Implanted Infusion Ports,” FDA October 1990.